Interferon-alpha in malignant and viral diseases. A review.
about
IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception.Treatment of chronic hepatitis C virus infection in patients with cirrhosis.Behavioral evaluation of transgenic mice with CNS expression of IFN-alpha by elevated plus-maze and Porsolt swim test.alpha-Interferon treatment of patients with chronic fatigue syndrome.Pharmacotherapy of recurrent respiratory papillomatosis.AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinoma.IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.Minocycline attenuates interferon-α-induced impairments in rat fear extinctionActivation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.Decreased immobility in swimming test by homologous interferon-alpha in mice accompanied with increased cerebral tryptophan level and serotonin turnover.The role of the systemic inflammatory response as a biomarker in immunotherapy for renal cell cancer.Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mRegulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics-small molecule drug interactions.Granulomatous bone marrow inflammation during treatment of chronic myeloid leukaemia with interferon alpha-2b.Immune-based therapies for treatment of HIV infection.Histamine in cancer immunotherapy.Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.Interferon alpha2b increases paracellular permeability of renal proximal tubular LLC-PK1 cells via a mitogen activated protein kinase signaling pathway.
P2860
Q22254705-122CBEEA-412B-4724-8C32-94E6345BB4DAQ33401583-1AA33B64-2F43-4F31-84CD-E009EA742398Q34022678-EF0F38A4-6D96-4BBA-BE80-A9A57A65DF93Q34023769-9ADC35A2-160B-4DDF-A78B-297F97AFE7A0Q34386229-A1A89198-2E4F-4A37-9335-E89E4CE35958Q34768490-82A5233D-83F3-45EB-A130-32A608E089FAQ35185775-042287F4-B013-489D-827F-00E20630D218Q36813334-F5CE1B2A-CDCE-446B-B4E8-097412EB197EQ37054821-158D7A5C-A545-4085-A7F2-5A932A8168CAQ37126943-EA920BC6-6FC3-4841-AA75-861E83654C4CQ37187585-1F427E3C-9F8A-4F81-AA28-9724A5FD471AQ37605784-1C1EE01E-8DC1-46D3-85D8-AEA7A1FEAC01Q38281944-720EACBA-48AC-4463-9A2F-528E951CF985Q39325953-9640CFAA-5F8F-45B6-9321-0D7ED078FC58Q39655315-FFC215E4-AFB5-48E6-8150-3B493B458B95Q40959127-41769316-949C-4958-B7D6-A2CFA4C8FFC0Q41546286-B7333C7C-F805-447A-B850-E8EA2BE66B19Q41605739-CD116CC4-4674-41C3-BB39-65398807E269Q42140547-CEE13311-F282-4BAE-A01E-8D7840B2853EQ42590933-FEC44B50-E12A-4836-A716-33028B5FF5CFQ43703540-F2FE2D8B-8FC3-4F05-B7D4-C4609C2FF58A
P2860
Interferon-alpha in malignant and viral diseases. A review.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Interferon-alpha in malignant and viral diseases. A review.
@en
type
label
Interferon-alpha in malignant and viral diseases. A review.
@en
prefLabel
Interferon-alpha in malignant and viral diseases. A review.
@en
P1433
P1476
Interferon-alpha in malignant and viral diseases. A review.
@en
P2093
P304
P356
10.2165/00003495-199345020-00003
P577
1993-02-01T00:00:00Z
P6179
1021702293